Baclofen analgesia: Involvement of the GABAergic system

Pharmacological Research

Volumn 46, Issue 3, 2002, Pages 281-286

  Balerio, Graciela N ^a,b   Rubio, Modesto C ^a,b  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b Instituto de Investigaciones Farmacologicas   (Argentina)

Author keywords

2 hydroxysaclofen; Analgesia; Baclofen; GABAB receptors

Indexed keywords

2 HYDROXYSACLOFEN; 4 AMINOBUTYRIC ACID B RECEPTOR; 4 AMINOBUTYRIC ACID B RECEPTOR BLOCKING AGENT; BACLOFEN;

ANALGESIA; ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; GABAERGIC SYSTEM; HOT PLATE TEST; MOTOR COORDINATION; MOTOR DYSFUNCTION; MOUSE; NONHUMAN; PHARMACOLOGICAL BLOCKING; PRIORITY JOURNAL; SEDATION;

EID: 0036421412     PISSN: 10436618     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1043-6618(02)00147-0     Document Type: Article

References (48)

1. DeFeudis FV. GABA receptors in the vertebrate nervous system. Prog Neurobiol 1977; 9: 123-45.
2. Hösli L, Hösli E. Action and uptake of neurotransmitters in CNS tissue culture. Rev Physiol Biochem Pharmacol 1978; 81: 135-88.
3. Johnston GAR. Neuropharmacology of aminoacid inhibitory transmitters. Annu Rev Pharmacol Toxicol 1978; 18: 269-89.
4. Bowery NG, Hill DR, Hudson AL, Doble A, Middlemiss DN, Shaw J, Turnbull MJ. (-)-Baclofen decreases neurotransmitter release in the mammalian CNS by an action at a novel GABA receptor. Nature 1980; 283: 92-4.
5. Bowery NG, Doble A, Hill DR, Hudson AL, Shaw JS, Turnbull MJ, Warrington R. Bicuculline-insensitive GABA receptors on peripheral autonomic nerve terminals. Eur J Pharmacol 1981; 71: 53-70.
6. B sites in rat brain. Nature 1981; 290: 149-52.
7. Ticku MK, Maksay G. Convulsant/depressant site of action at the allosteric benzodiazepine-GABA receptor-ionophore complex. Life Sci 1983; 33: 2363-75.
8. B receptor pharmacology. Annu Rev Pharmacol Toxicol 1993; 33: 109-47.
9. DeFeudis FV. GABAergic analgesia - A naloxone insensitive system. Pharmacol Res Commun 1982; 14: 383-90.
10. Sawynok J. GABAergic mechanisms in antinociception. Prog Neuropsychopharmacol Biol Psychiatry 1984; 8: 581-6.
11. Sivam SP, Ho IK. Minireview, GABA in morphine analgesia and tolerance. Life Sci 1985; 37: 199-208.
12. Metha AK, Ticku MK. Baclofen induces catatonia in rats. Neuropharmacology 1987; 26: 1419-23.
13. B receptor function in mice, is enhanced by antidepressant drugs and ECS. Br J Pharmacol 1987; 92: 863-70.
14. B agonist on forced swimming-induced immobility in mice. Arch Int Pharmacodyn 1990; 307: 18-31.
15. Sawynok J. GABAergic mechanism of analgesia: An update. Pharmacol Biochem Behav 1987; 26: 463-74.
16. Pedersen E, Arlien-Soborg P, Mai J. The mode of action of the GABA derivate baclofen in human spasticity. Acta Neurol Scand 1974; 50: 665-80.
17. Pinto O, De S, Polikar M, Debono G. Results of international clinical trials with Lioresal. Postgrad Med J 1972; 48(5): 18-23.
18. Davidoff RA, Sears ES. The effects of Lioresal on synaptic activity in the isolated spinal cord. Neurology 1974; 24: 957-63.
19. Pierau FK, Matheson GK, Wurster RD. Presynaptic action of β-(4-chlorophenyl)-GABA. Exp Neurol 1975; 48: 343-51.
20. Corly O, Roma G, Bacchini M, Battagliarini G, De Lorenzi PP. Il baclofen come analgesico negli interventi di dilatazione, aspirazioni e curretage uterino. Min Anest 1984; 50: 401-5.
21. Cutting DA, Jordan CC. Alternative approaches to analgesia: Baclofen as a model compound. Br J Pharmacol 1975; 54: 171-9.
22. Balerio GN, Rubio MC. Subsensitivity to baclofen-induced analgesia. Pharmacol Rev Commun 1996; 8: 87-92.
23. Eddy NB, Leimbach D. Synthetic analgesics. Dithienylbutenyl and dithienylbutylamines. J Pharmacol Exp Ther 1953; 107: 385-93.
24. Harris LS, Pierson AK. Some narcotic antagonists in the benzomorphan series. J Pharmacol Exp Ther 1964; 143: 141-8.
25. Ueda H, Amano H, Shiomi H, Takagi H. Comparison of the analgesic effects of various opioid peptides by a newly devised intracisternal injection technique in conscious mice. Eur J Pharmacol 1979; 56: 265-8.
26. Litchfield JT, Wilcoxon FJ. A simple method of evaluating dose-effect experiments. J Pharmacol Exp Ther 1949; 96: 99-113.
27. Sawynok J, LaBella FS. On the involvement of GABA in the analgesia produced by baclofen, muscimol and morphine. Neuropharmacology 1982; 21: 397-403.
28. Vaught JL, Pelley K, Costa LG, Setler P, Enna SJ. A comparison of the antinociceptive responses to the GABA receptor agonists THIP and baclofen. Neuropharmacology 1985; 24: 211-6.
29. B-mediated response. Methods Find Exp Clin Pharmacol 1991; 13(10): 681-6.
30. Paraglia F, Cella SG, Radice L, Genazzani AR, Muller EE. γ-Aminobutyric acid inhibits β-endorphin secretion from the anterior pituitary, but not the neurointermediate lobe in the rat. Endocrinology 1986; 118: 360-6.
31. Aley KO, Kulkarni SK. GABAergic agents induced antinociceptive effect in mice. Methods Find Exp Clin Pharmacol 1989; 11(10): 597-601.
32. DePaulis A, Morgan MM, Liebskind JC. GABAergic involvement in the antinociceptive effect of morphine at the level of the periaque-ductal gray matter in the rat. Proc West Pharmacol Soc 1985; 28: 143-5.
33. Bowery NG, Hudson AL, Price GW. GABA-A and GABA-B receptor site distribution in the rat central nervous system. Neuroscience 1987; 20: 365-83.
34. Aran S, Hammond DL. Antagonism of baclofen-induced antinociception by intrathecal administration of phaclofen or 2-hydroxy-saclofen, but not γ-aminovaleric acid in the rat. J Pharmacol Exp Ther 1991; 257: 360.
35. Liebman AR, Pastor G. Antinociceptive effects of baclofen and muscimol upon intraventricular administration. Eur J Pharmacol 1980; 61: 225-30.
36. Guiliani A, Evangelista S, Borsini F, Meli A. Intracerebroventricular phaclofen antagonizes baclofen antinociceptive activity in hot plate test with mice. Eur J Pharmacol 1988; 154: 225-6.
37. B antagonist, prevents antinociception and muscle-relaxant effect induced by baclofen. Br J Pharmacol 1991; 103: 1303-8.
38. B receptors. Eur J Pharmacol 1990; 187: 27-38.
39. Kerr DIB, Ong J, Johnston GAR, Abrenante J, Prager RH. 2-Hydroxy-saclofen: An improved antagonist at central and peripheral GABA-B receptors. Neurosci Lett 1988; 92: 92-6.
40. B receptors in the hippocampus have different pharmacological properties. Neuron 1988; 1: 585-98.
41. B receptors in the rat hippocampus by 2-hydroxy-saclofen. Neurosci Lett 1990; 119: 272-6.
42. B receptors on neurones in rat brain slices. Br J Pharmacol 1990; 101: 949-57.
43. Hammond DL, Washington JD. Antagonism of L-baclofen-induced antinociception by CGP 35348 in the spinal cord of the rat. Eur J Pharmacol 1993; 234: 255-62.
44. Allan AM, Harris RA. A new alcohol antagonist: Phaclofen. Life Sci 1989; 45: 1771-9.
45. B antagonists in mediating the effects of ethanol in mice. Psychopharmacology 1993; 3: 219-24.
46. B receptors. Trends Pharmacol Sci 1993; 14: 259-61.
47. 14C]-carboxyl-inulin across the blood-brain barrier and blood-spinal cord barrier in the rabbit. J Spinal Cord Med 1995; 18(4): 221-6.
48. Pan W, Banks WA, Kastin AJ. Permeability of the blood-brain and blood-spinal cord barriers to interferons. J Neuroimmunol 1997; 76(1/2): 105-11.